Skip to content

Clinical trials

Myeloproliferative Disorders trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Unknown status Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20052
20081
20091
20102
20132
20142
20161
20171
20182
20192
20203
20211
20224
20232
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Brest4
Assiut University3
Assistance Publique - Hôpitaux de Paris2
Shanghai Zhongshan Hospital2
Sohag University2
iCell Gene Therapeutics2
Carmel Medical Center1
Centre Hospitalier Universitaire de Nīmes1
European Organisation for Research and Treatment of Cancer - EORTC1
European Working Group of MDS in Childhood1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders37
Myelodysplastic Syndromes12
Leukemia11
Leukemia, Myeloid, Acute11
Multiple Myeloma8
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Leukemia, Lymphocytic, Chronic, B-Cell7
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative7
Leukemia, Myelomonocytic, Chronic7
Myelodysplastic-Myeloproliferative Diseases7

Trials

Showing 76 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.